Studies demonstrate 10-15% body weight reductions, positioning it as a powerful tool for obesity mechanism investigations
GLP-1 drugs are effective because they delay the stomach from emptying, creating a feeling of fullness, thereby having an increased effect on weight loss
Weight loss that reduces mechanical load on joints can, in turn, improve mobility and quality of life, a connection increasingly acknowledged in research
Published Phase 2 data (NEJM, 2023) showed retatrutide achieving up to 24.2% mean weight reduction at 48 weeks exceeding outcomes seen with dual GLP-1/GIP agonists
Understanding the biological relationship between migraine and depression
When an Integrative Approach Makes Sense There are situations where GLP-1 medications are medically necessary, particularly in advanced type 2 diabetes or severe metabolic disease